SYNTHESES OF ANTITUMOR AGENTS CALYCULIN AND SCYTOPHYCIN
抗肿瘤剂花萼蛋白和细胞霉素的合成
基本信息
- 批准号:3192205
- 负责人:
- 金额:$ 18.03万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1988
- 资助国家:美国
- 起止时间:1988-08-08 至 1993-05-31
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
This proposal is specifically aimed at the synthesis of the two
marine natural products calyculin A (1), C50H81N4015P, isolated
from the sponge Discodermia calyx, 1 and scytophycin C(2),
C45H74NO10, from the blue-green alga Scytonema
pseudohofmanni Bharadwaja. Both target molecules exhibit
remarkable antitumor activity. For instance, calyculin in highly
cytotoxic to tumor cells (IC50:1.75 x 10-3 mug/ml;L1210), while
the minimum toxic doses of scytophycins against KB human
epidermoid carcinoma and NIH/3T3 mouse fibroblast cell lines are
1 ng/mL and 0.65 ng/mL, respectively. This project, like its
predecessor, concerns the synthesis of potential antitumor agents
which meet two criteria: (1) their availability from natural
sources is severely limited and more importantly, (2) they
comprise synthetically attractive structural units, the
construction of which appears feasible by the application of newly
developed synthetic methods and/or reagents. Calyculin A and
Scytophycin C do indeed display such characteristics and hence
represent exciting synthetic targets.
Both 1 and 2 consist largely of polyketides and numerous 1,3-diol
units varying in structure and stereochemistry. The efficient
construction of these repeating units now appears practical (even
for complex molecules such as 1 and 2), using a full set of
homochiral reagents, most of which have been developed over the
past year for the stereoselective aldol reaction and allylboration.
In addition to this polyketide problem, calyculin A comprises a
novel spiro ketal of a rather unusual skeleton bearing phosphate,
oxazole, nitrile, and amide functionalities, while scytophycin C is
uniquely characterized by the presence of a N-methylformamide
group. Functional group assembly in the final stages of both
syntheses present a challenging task for which workable methods
are proposed. Natural products continue to provide the testing
grounds for concepts, synthetic strategies and methods. During
the synthetic pursuit they further help identify fundamental
problems yet to be investigated.
这一建议是专门针对两者的综合
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SATORU MASAMUNE其他文献
SATORU MASAMUNE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SATORU MASAMUNE', 18)}}的其他基金
SYNTHESES OF ANTITUMOR AGENTS CALYCULIN AND SCYTOPHYCIN
抗肿瘤剂花萼蛋白和细胞霉素的合成
- 批准号:
3192203 - 财政年份:1988
- 资助金额:
$ 18.03万 - 项目类别:
SYNTHESES OF ANTITUMOR AGENTS CALYCULIN AND SCYTOPHYCIN
抗肿瘤剂花萼蛋白和细胞霉素的合成
- 批准号:
3192200 - 财政年份:1988
- 资助金额:
$ 18.03万 - 项目类别:
SYNTHESES OF ANTITUMOR AGENTS CALYCULIN AND SCYTOPHYCIN
抗肿瘤剂花萼蛋白和细胞霉素的合成
- 批准号:
3192204 - 财政年份:1988
- 资助金额:
$ 18.03万 - 项目类别:
相似海外基金
Collaborative Research: NSF-DFG: CAS: Electrochemical Hydrogenation of Amides and Esters
合作研究:NSF-DFG:CAS:酰胺和酯的电化学氢化
- 批准号:
2140205 - 财政年份:2022
- 资助金额:
$ 18.03万 - 项目类别:
Standard Grant
Collaborative Research: NSF-DFG: CAS: Electrochemical Hydrogenation of Amides and Esters
合作研究:NSF-DFG:CAS:酰胺和酯的电化学氢化
- 批准号:
2140196 - 财政年份:2022
- 资助金额:
$ 18.03万 - 项目类别:
Standard Grant
Atroposelective Synthesis of Hindered Amides - Exploration of Synthetic Peptide Catalysts -
受阻酰胺的天体选择性合成-合成肽催化剂的探索-
- 批准号:
504378162 - 财政年份:2022
- 资助金额:
$ 18.03万 - 项目类别:
WBP Fellowship
Development of Peptide Chemical Modification Enabled by N-Halogenation of Amides
酰胺 N-卤化实现的肽化学修饰的发展
- 批准号:
22H02743 - 财政年份:2022
- 资助金额:
$ 18.03万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Modulating Signaling Endocannabinoids and Fatty Acid Amides
调节信号传导内源性大麻素和脂肪酸酰胺
- 批准号:
10532252 - 财政年份:2021
- 资助金额:
$ 18.03万 - 项目类别:
CAREER: SusChEM: Iron Catalysts for the Reduction of Amides
职业:SusChEM:用于还原酰胺的铁催化剂
- 批准号:
2146728 - 财政年份:2021
- 资助金额:
$ 18.03万 - 项目类别:
Continuing Grant
Modulating Signaling Endocannabinoids and Fatty Acid Amides
调节信号传导内源性大麻素和脂肪酸酰胺
- 批准号:
10399712 - 财政年份:2021
- 资助金额:
$ 18.03万 - 项目类别:
Function of primary fatty acid amides as lipid mediators
伯脂肪酸酰胺作为脂质介质的功能
- 批准号:
20K21285 - 财政年份:2020
- 资助金额:
$ 18.03万 - 项目类别:
Grant-in-Aid for Challenging Research (Exploratory)
Nickel-Catalyzed Alpha-Arylation of Secondary Amides
镍催化仲酰胺的α-芳基化
- 批准号:
558383-2020 - 财政年份:2020
- 资助金额:
$ 18.03万 - 项目类别:
Canadian Graduate Scholarships Foreign Study Supplements
Catalytic Synthesis of Pharmaceutical Amides in Water
水中催化合成药用酰胺
- 批准号:
EP/T01430X/1 - 财政年份:2020
- 资助金额:
$ 18.03万 - 项目类别:
Research Grant